Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Open Orphan announce 'substantial contract wins' with an existing client and UK government

Open Orphan announce 'substantial contract wins' with an existing client and UK government

Open Orphan PLC (LON:ORPH) Cathal Friel joins Proactive London with the news that it has won two new lines of business landing a €900,000 contract for clinical trial services through its Breda office in the Netherlands.

The contract is with an unnamed existing client which it describes as a 'world leader in vaccine and antiviral testing'.

Added to this the UK government is expanding a Coronavirus (COVID-19) characterisation study with the recruitment of a further 20 healthy volunteers to help in the fight against the virus.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK